Joseph L. Goldstein, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 16,916 shares at $580.65 ($10.0M) on 2020-06-08, disclosed to the SEC on 2020-06-09.
Open-market sale of $10.0M REGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $580.65 | 100 | $58K | 0.6% |
| 2 | $582.31 | 200 | $116K | 1.2% |
| 3 | $582.31 | 200 | $116K | 1.2% |
| 4 | $583.67 | 1,175 | $686K | 6.8% |
| 5 | $583.67 | 1,175 | $686K | 6.8% |
| 6 | $585.58 | 200 |
| $117K |
| 1.2% |
| 7 | $585.58 | 200 | $117K | 1.2% |
| 8 | $587.20 | 300 | $176K | 1.8% |
| 9 | $587.88 | 3,200 | $1.9M | 18.7% |
| 10 | $589.87 | 200 | $118K | 1.2% |
| 11 | $590.47 | 100 | $59K | 0.6% |
| 12 | $592.46 | 60 | $36K | 0.4% |
| 13 | $595.31 | 700 | $417K | 4.1% |
| 14 | $595.31 | 700 | $417K | 4.1% |
| 15 | $596.47 | 1,111 | $663K | 6.6% |
| 16 | $596.47 | 1,111 | $663K | 6.6% |
| 17 | $597.51 | 771 | $461K | 4.6% |
| 18 | $597.51 | 771 | $461K | 4.6% |
| 19 | $598.07 | 200 | $120K | 1.2% |
| 20 | $598.07 | 200 | $120K | 1.2% |
| 21 | $600.12 | 200 | $120K | 1.2% |
| 22 | $601.29 | 400 | $241K | 2.4% |
| 23 | $602.70 | 1,196 | $721K | 7.2% |
| 24 | $602.70 | 1,196 | $721K | 7.2% |
| 25 | $603.82 | 525 | $317K | 3.2% |
| 26 | $603.82 | 525 | $317K | 3.2% |
| 27 | $604.49 | 200 | $121K | 1.2% |
| Total | $593.71 avg | 16,916 | $10.0M | 100% |
| Filing → |
| REGN | SELL | 2022-04-01 | $1.7M | — | Filing → |
| REGN | SELL | 2021-09-13 | $1.6M | — | Filing → |
| REGN | SELL | 2021-06-08 | $1.0M | — | Filing → |